Archive - September 2023
GSK Exit not Responsible for Increase in Essential Drug Prices – NAFDAC DG
Handling Rejection (2)
Group seeks Inclusion, Appointment of Women with Disabilities in Governance
FDA Approves Ojjaara (momelotinib) for Myelofibrosis Patients with Anemia
NAFDAC Arrests Syndicate Importing Banned Mercury-Laden Soaps
Paediatrician Warns against Scarification as Cure for Convulsion
Resistance to Anti-Malaria Drugs not Rising in Nigeria- Expert
MIT’s new technique to remotely evaluate cerebral palsy patients